Compare TXRH & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TXRH | RVTY |
|---|---|---|
| Founded | 1993 | 1937 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.2B | 11.8B |
| IPO Year | 2004 | 1994 |
| Metric | TXRH | RVTY |
|---|---|---|
| Price | $162.98 | $88.94 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 19 | 16 |
| Target Price | ★ $194.53 | $111.87 |
| AVG Volume (30 Days) | 842.5K | ★ 950.1K |
| Earning Date | 05-07-2026 | 04-27-2026 |
| Dividend Yield | ★ 1.67% | 0.31% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 6.10 | 2.07 |
| Revenue | N/A | ★ $3,311,822,000.00 |
| Revenue This Year | $13.44 | $6.34 |
| Revenue Next Year | $9.27 | $5.10 |
| P/E Ratio | ★ $26.72 | $43.04 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $148.73 | $81.36 |
| 52 Week High | $199.99 | $118.30 |
| Indicator | TXRH | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 37.58 | 47.07 |
| Support Level | $156.74 | $88.47 |
| Resistance Level | $177.84 | $95.90 |
| Average True Range (ATR) | 4.51 | 2.94 |
| MACD | -0.33 | 0.72 |
| Stochastic Oscillator | 33.80 | 75.79 |
Texas Roadhouse Inc is a restaurant company operating predominantly in the casual dining segment. The company manages its restaurant and franchising operations by concept and, as a result, has identified Texas Roadhouse, Bubba's 33, Jaggers, and retail initiatives as separate operating segments. In addition, it has identified Texas Roadhouse and Bubba's 33 as reportable segments. Maximum revenue for the company is generated from the Texas Roadhouse segment, which is a moderately priced, full-service, casual dining restaurant concept offering steaks, a selection of ribs, seafood, chicken, pork chops, pulled pork, vegetable plates, and an assortment of hamburgers, salads, and sandwiches.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.